Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Share-based Compensation (2016 - 2026)

Intellia Therapeutics has reported Share-based Compensation over the past 12 years, most recently at $13.5 million for Q1 2026.

  • Quarterly Share-based Compensation fell 38.28% to $13.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $71.9 million through Mar 2026, down 49.37% year-over-year, with the annual reading at $80.2 million for FY2025, 48.0% down from the prior year.
  • Share-based Compensation was $13.5 million for Q1 2026 at Intellia Therapeutics, down from $16.7 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $40.9 million in Q2 2024 and troughed at $13.5 million in Q1 2026.
  • The 5-year median for Share-based Compensation is $25.2 million (2022), against an average of $27.8 million.
  • Year-over-year, Share-based Compensation soared 187.84% in 2022 and then crashed 57.75% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $24.6 million in 2022, then surged by 42.3% to $35.0 million in 2023, then rose by 13.05% to $39.6 million in 2024, then crashed by 57.75% to $16.7 million in 2025, then fell by 19.48% to $13.5 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Share-based Compensation are $13.5 million (Q1 2026), $16.7 million (Q4 2025), and $19.6 million (Q3 2025).